| Symbol |
Name |
Standardized Value |
|
JAK2
|
Janus kinase 2
|
3.991
|
|
CALR
|
calreticulin
|
3.655
|
|
JAK1
|
Janus kinase 1
|
3.5
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
3.371
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
3.346
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
3.315
|
|
SRSF2
|
serine/arginine-rich splicing factor 2
|
3.123
|
|
THPO
|
thrombopoietin
|
3.093
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
3.083
|
|
BCR
|
breakpoint cluster region
|
3.063
|
|
CD34
|
CD34 molecule
|
2.996
|
|
U2AF1
|
U2 small nuclear RNA auxiliary factor 1
|
2.958
|
|
JAK3
|
Janus kinase 3
|
2.864
|
|
EPO
|
erythropoietin
|
2.854
|
|
FLT3
|
fms-related tyrosine kinase 3
|
2.792
|
|
TYK2
|
tyrosine kinase 2
|
2.772
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
2.768
|
|
SH2B3
|
SH2B adaptor protein 3
|
2.763
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
2.746
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
2.734
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
2.68
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
2.649
|
|
RUNX1
|
runt-related transcription factor 1
|
2.645
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
2.613
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
2.608
|
|
IFNA1
|
interferon, alpha 1
|
2.594
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
2.579
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
2.537
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
2.528
|
|
EPOR
|
erythropoietin receptor
|
2.522
|
|
IFNA2
|
interferon, alpha 2
|
2.521
|
|
SETBP1
|
SET binding protein 1
|
2.509
|
|
IL6
|
interleukin 6
|
2.506
|
|
IL3
|
interleukin 3
|
2.489
|
|
NBEAL2
|
neurobeachin-like 2
|
2.463
|
|
TGFB1
|
transforming growth factor, beta 1
|
2.462
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
2.46
|
|
MPIG6B
|
megakaryocyte and platelet inhibitory receptor G6b
|
2.43
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
2.413
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
2.412
|
|
IFNA17
|
interferon, alpha 17
|
2.394
|
|
IFNA14
|
interferon, alpha 14
|
2.393
|
|
IFNA16
|
interferon, alpha 16
|
2.392
|
|
IFNA10
|
interferon, alpha 10
|
2.392
|
|
IFNA7
|
interferon, alpha 7
|
2.392
|
|
IFNA8
|
interferon, alpha 8
|
2.391
|
|
IFNA6
|
interferon, alpha 6
|
2.391
|
|
IFNA21
|
interferon, alpha 21
|
2.391
|
|
IFNA5
|
interferon, alpha 5
|
2.391
|
|
IFNA13
|
interferon, alpha 13
|
2.39
|
|
IFNA4
|
interferon, alpha 4
|
2.388
|
|
ZRSR2
|
zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2
|
2.385
|
|
PSMA7
|
proteasome (prosome, macropain) subunit, alpha type, 7
|
2.368
|
|
TP53
|
tumor protein p53
|
2.354
|
|
ETV6
|
ets variant 6
|
2.337
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
2.297
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
2.285
|
|
CD33
|
CD33 molecule
|
2.273
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
2.266
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
2.261
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
2.258
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
2.24
|
|
MATK
|
megakaryocyte-associated tyrosine kinase
|
2.238
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
2.235
|
|
IFNG
|
interferon, gamma
|
2.229
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
2.204
|
|
CD38
|
CD38 molecule
|
2.172
|
|
FEN1
|
flap structure-specific endonuclease 1
|
2.169
|
|
TNF
|
tumor necrosis factor
|
2.166
|
|
KITLG
|
KIT ligand
|
2.163
|
|
ACVR1
|
activin A receptor, type I
|
2.163
|
|
FIP1L1
|
factor interacting with PAPOLA and CPSF1
|
2.162
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
2.159
|
|
IL1B
|
interleukin 1, beta
|
2.155
|
|
BCL2L1
|
BCL2-like 1
|
2.151
|
|
MPO
|
myeloperoxidase
|
2.142
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
2.132
|
|
PF4
|
platelet factor 4
|
2.128
|
|
CD19
|
CD19 molecule
|
2.111
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
2.108
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
2.107
|
|
CD8A
|
CD8a molecule
|
2.106
|
|
CD4
|
CD4 molecule
|
2.104
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
2.104
|
|
GATA2
|
GATA binding protein 2
|
2.102
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
2.096
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
2.091
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
2.091
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
2.077
|
|
IL2
|
interleukin 2
|
2.069
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
2.058
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
2.047
|
|
IL7
|
interleukin 7
|
2.046
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
2.039
|
|
HAMP
|
hepcidin antimicrobial peptide
|
2.037
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
2.027
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
2.025
|
|
IL15
|
interleukin 15
|
2.022
|
|
VWF
|
von Willebrand factor
|
2.02
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
2.012
|
|
CRP
|
C-reactive protein, pentraxin-related
|
2.012
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
1.995
|
|
IL1A
|
interleukin 1, alpha
|
1.995
|
|
STAG2
|
stromal antigen 2
|
1.994
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
1.994
|
|
SETD2
|
SET domain containing 2
|
1.99
|
|
VPS45
|
vacuolar protein sorting 45 homolog (S. cerevisiae)
|
1.988
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
1.987
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
1.983
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
1.982
|
|
IL10
|
interleukin 10
|
1.977
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
1.956
|
|
GLI1
|
GLI family zinc finger 1
|
1.953
|
|
NFE2
|
nuclear factor, erythroid 2
|
1.952
|
|
STUB1
|
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase
|
1.952
|
|
FN1
|
fibronectin 1
|
1.95
|
|
IL11
|
interleukin 11
|
1.949
|
|
APCS
|
amyloid P component, serum
|
1.939
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
1.937
|
|
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3
|
1.935
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
1.931
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
1.929
|
|
CD7
|
CD7 molecule
|
1.926
|
|
SLAMF1
|
signaling lymphocytic activation molecule family member 1
|
1.925
|
|
TFRC
|
transferrin receptor
|
1.915
|
|
NCAM1
|
neural cell adhesion molecule 1
|
1.904
|
|
BRD4
|
bromodomain containing 4
|
1.903
|
|
GYPA
|
glycophorin A (MNS blood group)
|
1.899
|
|
IL4
|
interleukin 4
|
1.89
|
|
WT1
|
Wilms tumor 1
|
1.885
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
1.88
|
|
ZNF77
|
zinc finger protein 77
|
1.873
|
|
AAK1
|
AP2 associated kinase 1
|
1.872
|
|
GFI1B
|
growth factor independent 1B transcription repressor
|
1.869
|
|
CD5
|
CD5 molecule
|
1.863
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
1.862
|
|
CISH
|
cytokine inducible SH2-containing protein
|
1.861
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
1.859
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
1.855
|
|
RARA
|
retinoic acid receptor, alpha
|
1.852
|
|
ETNK1
|
ethanolamine kinase 1
|
1.85
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
1.844
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
1.84
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
1.84
|
|
IL17A
|
interleukin 17A
|
1.838
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
1.837
|
|
MCL1
|
myeloid cell leukemia 1
|
1.833
|
|
PTH
|
parathyroid hormone
|
1.821
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
1.811
|
|
CD177
|
CD177 molecule
|
1.81
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
1.808
|
|
ALB
|
albumin
|
1.806
|
|
STAT2
|
signal transducer and activator of transcription 2, 113kDa
|
1.801
|
|
LOXL2
|
lysyl oxidase-like 2
|
1.8
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
1.798
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
1.798
|
|
HDAC9
|
histone deacetylase 9
|
1.794
|
|
TERT
|
telomerase reverse transcriptase
|
1.791
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
1.781
|
|
SYK
|
spleen tyrosine kinase
|
1.775
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
1.765
|
|
H3C13
|
H3 clustered histone 13
|
1.764
|
|
H3C12
|
H3 clustered histone 12
|
1.763
|
|
H3-3B
|
H3.3 histone B
|
1.76
|
|
H3-4
|
H3.4 histone, cluster member
|
1.76
|
|
H3-5
|
H3.5 histone
|
1.76
|
|
CUX1
|
cut-like homeobox 1
|
1.755
|
|
PHF6
|
PHD finger protein 6
|
1.752
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
1.744
|
|
AURKA
|
aurora kinase A
|
1.743
|
|
CD274
|
CD274 molecule
|
1.741
|
|
FLT3LG
|
fms-related tyrosine kinase 3 ligand
|
1.735
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
1.729
|
|
IL13
|
interleukin 13
|
1.728
|
|
EGFR
|
epidermal growth factor receptor
|
1.727
|
|
CD48
|
CD48 molecule
|
1.725
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
1.72
|
|
IL9
|
interleukin 9
|
1.719
|
|
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit
|
1.712
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
1.711
|
|
PPBP
|
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
|
1.707
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
1.704
|
|
F2
|
coagulation factor II (thrombin)
|
1.701
|
|
SLC22A12
|
solute carrier family 22 (organic anion/urate transporter), member 12
|
1.701
|
|
LOX
|
lysyl oxidase
|
1.701
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
1.698
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
1.692
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
1.692
|
|
MME
|
membrane metallo-endopeptidase
|
1.685
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
1.682
|
|
SPN
|
sialophorin
|
1.682
|
|
CHP1
|
calcineurin-like EF-hand protein 1
|
1.681
|
|
CD2
|
CD2 molecule
|
1.68
|
|
MAPRE2
|
microtubule-associated protein, RP/EB family, member 2
|
1.678
|
|
IL5
|
interleukin 5
|
1.674
|
|
BCORL1
|
BCL6 corepressor-like 1
|
1.669
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
1.666
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
1.665
|
|
CD68
|
CD68 molecule
|
1.659
|
|
CCND1
|
cyclin D1
|
1.657
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
1.656
|
|
EVPL
|
envoplakin
|
1.656
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
1.654
|
|
LOC102723407
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8
|
1.653
|
|
CRLF2
|
cytokine receptor-like factor 2
|
1.649
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
1.646
|
|
LEPR
|
leptin receptor
|
1.645
|
|
THY1
|
Thy-1 cell surface antigen
|
1.643
|
|
RDX
|
radixin
|
1.639
|
|
EGF
|
epidermal growth factor
|
1.63
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
1.63
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
1.628
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
1.627
|
|
IL6R
|
interleukin 6 receptor
|
1.626
|
|
SSBP2
|
single-stranded DNA binding protein 2
|
1.622
|
|
HOXA9
|
homeobox A9
|
1.613
|
|
PRMT5
|
protein arginine methyltransferase 5
|
1.61
|
|
PF4V1
|
platelet factor 4 variant 1
|
1.61
|
|
NES
|
nestin
|
1.608
|
|
OSM
|
oncostatin M
|
1.604
|
|
NUP98
|
nucleoporin 98kDa
|
1.598
|
|
MSN
|
moesin
|
1.597
|
|
GAK
|
cyclin G associated kinase
|
1.594
|
|
JARID2
|
jumonji, AT rich interactive domain 2
|
1.594
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
1.589
|
|
MX1
|
MX dynamin-like GTPase 1
|
1.589
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
1.587
|
|
SLCO2A1
|
solute carrier organic anion transporter family, member 2A1
|
1.587
|
|
ANKRD26
|
ankyrin repeat domain 26
|
1.585
|
|
GOLGA4
|
golgin A4
|
1.582
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
1.582
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
1.582
|
|
BRD2
|
bromodomain containing 2
|
1.58
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
1.577
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
1.575
|
|
ENG
|
endoglin
|
1.575
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
1.574
|
|
IL7R
|
interleukin 7 receptor
|
1.574
|
|
SDC1
|
syndecan 1
|
1.572
|
|
BCL2L2
|
BCL2-like 2
|
1.571
|
|
PAX5
|
paired box 5
|
1.57
|
|
ANXA5
|
annexin A5
|
1.569
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
1.568
|
|
BRDT
|
bromodomain, testis-specific
|
1.563
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
1.559
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
1.559
|
|
FGF4
|
fibroblast growth factor 4
|
1.557
|
|
SPI1
|
Spi-1 proto-oncogene
|
1.557
|
|
CD22
|
CD22 molecule
|
1.556
|
|
NF1
|
neurofibromin 1
|
1.553
|
|
MYH11
|
myosin, heavy chain 11, smooth muscle
|
1.55
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
1.549
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
1.547
|
|
RPS14
|
ribosomal protein S14
|
1.546
|
|
IL18
|
interleukin 18
|
1.545
|
|
B2M
|
beta-2-microglobulin
|
1.545
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
1.544
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
1.54
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
1.538
|
|
GSKIP
|
GSK3B interacting protein
|
1.535
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
1.535
|
|
VPS33B
|
vacuolar protein sorting 33 homolog B (yeast)
|
1.534
|
|
PXDNL
|
peroxidasin-like
|
1.53
|
|
NOTCH1
|
notch 1
|
1.529
|
|
PXDN
|
peroxidasin
|
1.529
|
|
EZR
|
ezrin
|
1.527
|
|
STAT4
|
signal transducer and activator of transcription 4
|
1.526
|
|
BRD3
|
bromodomain containing 3
|
1.525
|
|
CD44
|
CD44 molecule (Indian blood group)
|
1.524
|
|
FGF3
|
fibroblast growth factor 3
|
1.524
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
1.522
|
|
FGF6
|
fibroblast growth factor 6
|
1.519
|
|
FGF22
|
fibroblast growth factor 22
|
1.518
|
|
KLF1
|
Kruppel-like factor 1 (erythroid)
|
1.518
|
|
HMGA2
|
high mobility group AT-hook 2
|
1.518
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
1.517
|
|
FGF7
|
fibroblast growth factor 7
|
1.516
|
|
VIPAS39
|
VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog
|
1.516
|
|
FGF16
|
fibroblast growth factor 16
|
1.516
|
|
FGF5
|
fibroblast growth factor 5
|
1.515
|
|
FGF17
|
fibroblast growth factor 17
|
1.515
|
|
FGF20
|
fibroblast growth factor 20
|
1.513
|
|
FGF9
|
fibroblast growth factor 9
|
1.513
|
|
FGF18
|
fibroblast growth factor 18
|
1.511
|
|
PCM1
|
pericentriolar material 1
|
1.509
|
|
SMAD2
|
SMAD family member 2
|
1.508
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
1.506
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
1.505
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
1.5
|
|
FGF10
|
fibroblast growth factor 10
|
1.499
|
|
DDX41
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 41
|
1.499
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
1.498
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
1.497
|
|
EPB41
|
erythrocyte membrane protein band 4.1
|
1.49
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
1.489
|
|
FOXP3
|
forkhead box P3
|
1.489
|
|
GP6
|
glycoprotein VI (platelet)
|
1.488
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
1.486
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
1.486
|
|
IL22
|
interleukin 22
|
1.486
|
|
PIGA
|
phosphatidylinositol glycan anchor biosynthesis, class A
|
1.485
|
|
SPP1
|
secreted phosphoprotein 1
|
1.484
|
|
COL1A1
|
collagen, type I, alpha 1
|
1.481
|
|
ZFPM1
|
zinc finger protein, FOG family member 1
|
1.48
|
|
MYD88
|
myeloid differentiation primary response 88
|
1.467
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
1.464
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
1.464
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
1.46
|
|
MLLT10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10
|
1.459
|
|
ACTB
|
actin, beta
|
1.459
|
|
KDR
|
kinase insert domain receptor
|
1.458
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
1.456
|
|
MMP9
|
matrix metallopeptidase 9
|
1.453
|
|
ATM
|
ATM serine/threonine kinase
|
1.453
|
|
SOCS2
|
suppressor of cytokine signaling 2
|
1.452
|
|
KDM6A
|
lysine (K)-specific demethylase 6A
|
1.451
|
|
MRTFA
|
myocardin related transcription factor A
|
1.449
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
1.449
|
|
CD1C
|
CD1c molecule
|
1.44
|
|
JUN
|
jun proto-oncogene
|
1.437
|
|
CHIC2
|
cysteine-rich hydrophobic domain 2
|
1.436
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
1.434
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
1.431
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
1.428
|
|
CBFB
|
core-binding factor, beta subunit
|
1.422
|
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
1.42
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
1.42
|
|
DNTT
|
DNA nucleotidylexotransferase
|
1.418
|
|
RUNX2
|
runt-related transcription factor 2
|
1.418
|
|
TLR4
|
toll-like receptor 4
|
1.414
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
1.414
|
|
PTEN
|
phosphatase and tensin homolog
|
1.413
|
|
CD47
|
CD47 molecule
|
1.409
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
1.408
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
1.406
|
|
FER
|
fer (fps/fes related) tyrosine kinase
|
1.404
|
|
CDK4
|
cyclin-dependent kinase 4
|
1.398
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
1.396
|
|
RET
|
ret proto-oncogene
|
1.393
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
1.393
|
|
EED
|
embryonic ectoderm development
|
1.39
|
|
CDC42
|
cell division cycle 42
|
1.388
|
|
MEIS1
|
Meis homeobox 1
|
1.388
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
1.387
|
|
PIM2
|
Pim-2 proto-oncogene, serine/threonine kinase
|
1.387
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
1.387
|
|
SLAMF7
|
SLAM family member 7
|
1.386
|
|
IFNAR2
|
interferon (alpha, beta and omega) receptor 2
|
1.385
|
|
ZMYM2
|
zinc finger, MYM-type 2
|
1.384
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
1.384
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
1.383
|
|
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3
|
1.383
|
|
SMAD3
|
SMAD family member 3
|
1.382
|
|
DOT1L
|
DOT1-like histone H3K79 methyltransferase
|
1.381
|
|
CRBN
|
cereblon
|
1.38
|
|
CD1A
|
CD1a molecule
|
1.379
|
|
CD52
|
CD52 molecule
|
1.378
|
|
ANGPT1
|
angiopoietin 1
|
1.378
|
|
LIF
|
leukemia inhibitory factor
|
1.377
|
|
NUP214
|
nucleoporin 214kDa
|
1.377
|
|
IL1R1
|
interleukin 1 receptor, type I
|
1.373
|
|
THBS1
|
thrombospondin 1
|
1.37
|
|
CD1E
|
CD1e molecule
|
1.369
|
|
HP
|
haptoglobin
|
1.368
|
|
TGFB3
|
transforming growth factor, beta 3
|
1.368
|
|
CD28
|
CD28 molecule
|
1.365
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
1.364
|
|
SMC3
|
structural maintenance of chromosomes 3
|
1.364
|
|
GP9
|
glycoprotein IX (platelet)
|
1.361
|
|
TET1
|
tet methylcytosine dioxygenase 1
|
1.36
|
|
AGO2
|
argonaute RISC catalytic component 2
|
1.359
|
|
CD1B
|
CD1b molecule
|
1.358
|
|
IRF9
|
interferon regulatory factor 9
|
1.356
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
1.354
|
|
EP300
|
E1A binding protein p300
|
1.353
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
1.351
|
|
KDM4C
|
lysine (K)-specific demethylase 4C
|
1.351
|
|
CD1D
|
CD1d molecule
|
1.351
|
|
IFNGR2
|
interferon gamma receptor 2 (interferon gamma transducer 1)
|
1.35
|
|
AFF1
|
AF4/FMR2 family, member 1
|
1.346
|
|
CDK6
|
cyclin-dependent kinase 6
|
1.343
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
1.341
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
1.338
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
1.335
|
|
ASXL2
|
additional sex combs like transcriptional regulator 2
|
1.334
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
1.332
|
|
LCN2
|
lipocalin 2
|
1.33
|
|
CD27
|
CD27 molecule
|
1.327
|
|
CD163
|
CD163 molecule
|
1.325
|
|
ACE2
|
angiotensin I converting enzyme 2
|
1.324
|
|
BAX
|
BCL2-associated X protein
|
1.323
|
|
SP7
|
Sp7 transcription factor
|
1.32
|
|
PLEK
|
pleckstrin
|
1.318
|
|
ACE
|
angiotensin I converting enzyme
|
1.318
|
|
SIRPA
|
signal-regulatory protein alpha
|
1.317
|
|
SCARB2
|
scavenger receptor class B, member 2
|
1.314
|
|
AURKB
|
aurora kinase B
|
1.31
|
|
BMP4
|
bone morphogenetic protein 4
|
1.309
|
|
ITGAV
|
integrin, alpha V
|
1.309
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
1.308
|
|
IL31
|
interleukin 31
|
1.306
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
1.303
|
|
CD86
|
CD86 molecule
|
1.303
|
|
PIAS3
|
protein inhibitor of activated STAT, 3
|
1.302
|
|
THBD
|
thrombomodulin
|
1.302
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
1.301
|
|
TSLP
|
thymic stromal lymphopoietin
|
1.301
|
|
FGR
|
FGR proto-oncogene, Src family tyrosine kinase
|
1.301
|
|
CD40LG
|
CD40 ligand
|
1.301
|
|
PLEK2
|
pleckstrin 2
|
1.3
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
1.298
|
|
FLT1
|
fms-related tyrosine kinase 1
|
1.296
|
|
CLEC1B
|
C-type lectin domain family 1, member B
|
1.296
|
|
SMO
|
smoothened, frizzled class receptor
|
1.296
|
|
JAG1
|
jagged 1
|
1.295
|
|
RAD21
|
RAD21 homolog (S. pombe)
|
1.293
|
|
SCARB1
|
scavenger receptor class B, member 1
|
1.292
|
|
MYOM2
|
myomesin 2
|
1.291
|
|
RBM15
|
RNA binding motif protein 15
|
1.291
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
1.289
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
1.287
|
|
ICAM1
|
intercellular adhesion molecule 1
|
1.287
|
|
ELN
|
elastin
|
1.286
|
|
ITK
|
IL2-inducible T-cell kinase
|
1.285
|
|
TGFB2
|
transforming growth factor, beta 2
|
1.284
|
|
RHOA
|
ras homolog family member A
|
1.284
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
1.284
|
|
GNAS
|
GNAS complex locus
|
1.283
|
|
PROM1
|
prominin 1
|
1.281
|
|
CD80
|
CD80 molecule
|
1.28
|
|
HDAC6
|
histone deacetylase 6
|
1.28
|
|
HBS1L
|
HBS1-like translational GTPase
|
1.278
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
1.278
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
1.277
|
|
CEACAM8
|
carcinoembryonic antigen-related cell adhesion molecule 8
|
1.274
|
|
PTCH1
|
patched 1
|
1.272
|
|
LEP
|
leptin
|
1.272
|
|
PDCD1
|
programmed cell death 1
|
1.271
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
1.271
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
1.27
|
|
POSTN
|
periostin, osteoblast specific factor
|
1.27
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
1.269
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
1.264
|
|
SOCS4
|
suppressor of cytokine signaling 4
|
1.264
|
|
QRSL1
|
glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1
|
1.262
|
|
CHEK2
|
checkpoint kinase 2
|
1.259
|
|
CD9
|
CD9 molecule
|
1.258
|
|
HEXIM1
|
hexamethylene bis-acetamide inducible 1
|
1.258
|
|
IFI27
|
interferon, alpha-inducible protein 27
|
1.257
|
|
SHH
|
sonic hedgehog
|
1.254
|
|
ABL2
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
1.253
|
|
ELANE
|
elastase, neutrophil expressed
|
1.251
|
|
NGFR
|
nerve growth factor receptor
|
1.248
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
1.247
|
|
PPIG
|
peptidylprolyl isomerase G (cyclophilin G)
|
1.246
|
|
CDK9
|
cyclin-dependent kinase 9
|
1.244
|
|
LOXL1
|
lysyl oxidase-like 1
|
1.244
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
1.242
|
|
SMAD4
|
SMAD family member 4
|
1.241
|
|
TET3
|
tet methylcytosine dioxygenase 3
|
1.239
|
|
SELPLG
|
selectin P ligand
|
1.239
|
|
PRF1
|
perforin 1 (pore forming protein)
|
1.239
|
|
DEK
|
DEK proto-oncogene
|
1.238
|
|
CREBBP
|
CREB binding protein
|
1.233
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
1.232
|
|
LOXL3
|
lysyl oxidase-like 3
|
1.229
|
|
GP1BB
|
glycoprotein Ib (platelet), beta polypeptide
|
1.229
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
1.229
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
1.229
|
|
IL4R
|
interleukin 4 receptor
|
1.227
|
|
KDM5A
|
lysine (K)-specific demethylase 5A
|
1.227
|
|
COMMD3-BMI1
|
COMMD3-BMI1 readthrough
|
1.227
|
|
TBK1
|
TANK-binding kinase 1
|
1.226
|
|
MMP2
|
matrix metallopeptidase 2
|
1.225
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
1.223
|
|
ATG2B
|
autophagy related 2B
|
1.222
|
|
IFNGR1
|
interferon gamma receptor 1
|
1.221
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
1.22
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
1.216
|
|
IRF1
|
interferon regulatory factor 1
|
1.216
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
1.213
|
|
BMP7
|
bone morphogenetic protein 7
|
1.21
|
|
EPB42
|
erythrocyte membrane protein band 4.2
|
1.208
|
|
PKM
|
pyruvate kinase, muscle
|
1.208
|
|
ACVR2A
|
activin A receptor, type IIA
|
1.206
|
|
ALAS2
|
5'-aminolevulinate synthase 2
|
1.206
|
|
SEC31A
|
SEC31 homolog A (S. cerevisiae)
|
1.205
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
1.204
|
|
GLIS2
|
GLIS family zinc finger 2
|
1.203
|
|
BRCA1
|
breast cancer 1, early onset
|
1.203
|
|
BMP6
|
bone morphogenetic protein 6
|
1.202
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
1.202
|
|
ESR1
|
estrogen receptor 1
|
1.201
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
1.2
|
|
IRF3
|
interferon regulatory factor 3
|
1.2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
1.2
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
1.196
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
1.195
|
|
PRL
|
prolactin
|
1.194
|
|
IRF4
|
interferon regulatory factor 4
|
1.192
|
|
SELE
|
selectin E
|
1.192
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
1.191
|
|
FKBP4
|
FK506 binding protein 4, 59kDa
|
1.191
|
|
MCAM
|
melanoma cell adhesion molecule
|
1.189
|
|
XPO1
|
exportin 1
|
1.189
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
1.188
|
|
PIM3
|
Pim-3 proto-oncogene, serine/threonine kinase
|
1.187
|
|
SELL
|
selectin L
|
1.187
|
|
EBF1
|
early B-cell factor 1
|
1.186
|
|
ASPG
|
asparaginase
|
1.185
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
1.185
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
1.185
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
1.184
|
|
FGF23
|
fibroblast growth factor 23
|
1.183
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
1.182
|
|
IL6ST
|
interleukin 6 signal transducer
|
1.182
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
1.18
|
|
HDAC1
|
histone deacetylase 1
|
1.179
|
|
COL3A1
|
collagen, type III, alpha 1
|
1.179
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
1.178
|
|
GFI1
|
growth factor independent 1 transcription repressor
|
1.177
|
|
CCN2
|
cellular communication network factor 2
|
1.176
|
|
PCGF1
|
polycomb group ring finger 1
|
1.176
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
1.175
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
1.175
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
1.174
|
|
IRF7
|
interferon regulatory factor 7
|
1.17
|
|
AXL
|
AXL receptor tyrosine kinase
|
1.168
|
|
ITGAE
|
integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)
|
1.167
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
1.167
|
|
TUBB
|
tubulin, beta class I
|
1.166
|
|
ABCB7
|
ATP-binding cassette, sub-family B (MDR/TAP), member 7
|
1.166
|
|
PTS
|
6-pyruvoyltetrahydropterin synthase
|
1.164
|
|
AR
|
androgen receptor
|
1.163
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
1.163
|
|
MLLT1
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1
|
1.162
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
1.16
|
|
BMP1
|
bone morphogenetic protein 1
|
1.159
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
1.158
|
|
EGR1
|
early growth response 1
|
1.158
|
|
SOCS7
|
suppressor of cytokine signaling 7
|
1.157
|
|
BMP2
|
bone morphogenetic protein 2
|
1.155
|
|
GDF11
|
growth differentiation factor 11
|
1.154
|
|
CHEK1
|
checkpoint kinase 1
|
1.152
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
1.152
|
|
MPP3
|
membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3)
|
1.15
|
|
RBBP6
|
retinoblastoma binding protein 6
|
1.15
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
1.148
|
|
PRPF8
|
pre-mRNA processing factor 8
|
1.148
|
|
LOXL4
|
lysyl oxidase-like 4
|
1.147
|
|
SOCS6
|
suppressor of cytokine signaling 6
|
1.147
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
1.147
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
1.146
|
|
CDK2
|
cyclin-dependent kinase 2
|
1.144
|
|
GRB2
|
growth factor receptor-bound protein 2
|
1.142
|
|
INSL6
|
insulin-like 6
|
1.142
|
|
AIM2
|
absent in melanoma 2
|
1.142
|
|
CDK1
|
cyclin-dependent kinase 1
|
1.141
|
|
GAB2
|
GRB2-associated binding protein 2
|
1.141
|
|
SBDS
|
Shwachman-Bodian-Diamond syndrome
|
1.139
|
|
BCL2A1
|
BCL2-related protein A1
|
1.139
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
1.138
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
1.138
|
|
CTF1
|
cardiotrophin 1
|
1.137
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
1.137
|
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
1.136
|
|
TBX21
|
T-box 21
|
1.133
|
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
1.133
|
|
INSL4
|
insulin-like 4 (placenta)
|
1.132
|
|
DEFA4
|
defensin, alpha 4, corticostatin
|
1.13
|
|
TLR3
|
toll-like receptor 3
|
1.129
|
|
SOST
|
sclerostin
|
1.129
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
1.128
|
|
GLI2
|
GLI family zinc finger 2
|
1.128
|
|
CYCS
|
cytochrome c, somatic
|
1.128
|
|
IL19
|
interleukin 19
|
1.128
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
1.128
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
1.127
|
|
PLG
|
plasminogen
|
1.125
|
|
IL33
|
interleukin 33
|
1.125
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
1.125
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
1.123
|
|
PLK1
|
polo-like kinase 1
|
1.122
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
1.121
|
|
HSPA4
|
heat shock 70kDa protein 4
|
1.118
|
|
INS
|
insulin
|
1.117
|
|
STIM1
|
stromal interaction molecule 1
|
1.116
|
|
CD63
|
CD63 molecule
|
1.114
|
|
LUC7L2
|
LUC7-like 2 (S. cerevisiae)
|
1.113
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
1.113
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
1.112
|
|
KMT2C
|
lysine (K)-specific methyltransferase 2C
|
1.112
|
|
IL1RAP
|
interleukin 1 receptor accessory protein
|
1.109
|
|
CALM3
|
calmodulin 3 (phosphorylase kinase, delta)
|
1.109
|
|
COL1A2
|
collagen, type I, alpha 2
|
1.108
|
|
FOXO3
|
forkhead box O3
|
1.107
|
|
CSNK1A1
|
casein kinase 1, alpha 1
|
1.105
|
|
RAG2
|
recombination activating gene 2
|
1.105
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
1.104
|
|
SF3A1
|
splicing factor 3a, subunit 1, 120kDa
|
1.103
|
|
FGF13
|
fibroblast growth factor 13
|
1.102
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
1.1
|
|
TCF3
|
transcription factor 3
|
1.1
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
1.1
|
|
F8
|
coagulation factor VIII, procoagulant component
|
1.098
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
1.098
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
1.097
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
1.097
|
|
ARG1
|
arginase 1
|
1.096
|
|
TLR7
|
toll-like receptor 7
|
1.096
|
|
OSMR
|
oncostatin M receptor
|
1.096
|
|
MDM4
|
MDM4, p53 regulator
|
1.095
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
1.094
|
|
HOXB4
|
homeobox B4
|
1.093
|
|
KAT6A
|
K(lysine) acetyltransferase 6A
|
1.093
|
|
CTSG
|
cathepsin G
|
1.092
|
|
POU5F1
|
POU class 5 homeobox 1
|
1.09
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
1.09
|
|
DPP4
|
dipeptidyl-peptidase 4
|
1.089
|
|
IKZF3
|
IKAROS family zinc finger 3 (Aiolos)
|
1.089
|
|
USB1
|
U6 snRNA biogenesis 1
|
1.086
|
|
PI3
|
peptidase inhibitor 3, skin-derived
|
1.086
|
|
IKZF5
|
IKAROS family zinc finger 5 (Pegasus)
|
1.083
|
|
MPND
|
MPN domain containing
|
1.082
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
1.082
|
|
CALML3
|
calmodulin-like 3
|
1.082
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
1.08
|
|
PTX3
|
pentraxin 3, long
|
1.077
|
|
CALML6
|
calmodulin-like 6
|
1.076
|
|
TLR9
|
toll-like receptor 9
|
1.076
|
|
CALML4
|
calmodulin-like 4
|
1.076
|
|
NAAA
|
N-acylethanolamine acid amidase
|
1.075
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
1.075
|
|
CALML5
|
calmodulin-like 5
|
1.073
|
|
CSK
|
c-src tyrosine kinase
|
1.072
|
|
PRTN3
|
proteinase 3
|
1.07
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
1.07
|
|
EPAS1
|
endothelial PAS domain protein 1
|
1.069
|
|
LIFR
|
leukemia inhibitory factor receptor alpha
|
1.069
|
|
NOTCH2
|
notch 2
|
1.069
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
1.068
|
|
FMC1-LUC7L2
|
FMC1-LUC7L2 readthrough
|
1.067
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
1.067
|
|
GPT2
|
glutamic pyruvate transaminase (alanine aminotransferase) 2
|
1.066
|
|
TCIRG1
|
T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3
|
1.066
|
|
CLEC12A
|
C-type lectin domain family 12, member A
|
1.065
|
|
CCND2
|
cyclin D2
|
1.064
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
1.064
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
1.062
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
1.062
|
|
CD69
|
CD69 molecule
|
1.061
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
1.06
|
|
BPGM
|
2,3-bisphosphoglycerate mutase
|
1.057
|
|
FKBP5
|
FK506 binding protein 5
|
1.056
|
|
CD164
|
CD164 molecule, sialomucin
|
1.055
|
|
SMARCD2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2
|
1.055
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
1.054
|
|
H2AC20
|
H2A clustered histone 20
|
1.053
|
|
IRF8
|
interferon regulatory factor 8
|
1.053
|
|
H2AC18
|
H2A clustered histone 18
|
1.052
|
|
PCGF2
|
polycomb group ring finger 2
|
1.052
|
|
FAS
|
Fas cell surface death receptor
|
1.052
|
|
PROCR
|
protein C receptor, endothelial
|
1.052
|
|
U2AF2
|
U2 small nuclear RNA auxiliary factor 2
|
1.051
|
|
KLRC1
|
killer cell lectin-like receptor subfamily C, member 1
|
1.05
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
1.048
|
|
RARG
|
retinoic acid receptor, gamma
|
1.047
|
|
HDAC11
|
histone deacetylase 11
|
1.047
|
|
SAA2
|
serum amyloid A2
|
1.047
|
|
CD24
|
CD24 molecule
|
1.046
|
|
UBA1
|
ubiquitin-like modifier activating enzyme 1
|
1.044
|
|
CEP70
|
centrosomal protein 70kDa
|
1.044
|
|
DIAPH1
|
diaphanous-related formin 1
|
1.042
|
|
KDM2B
|
lysine (K)-specific demethylase 2B
|
1.041
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
1.039
|
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta
|
1.039
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
1.039
|
|
PDIA3
|
protein disulfide isomerase family A, member 3
|
1.037
|
|
GATA3
|
GATA binding protein 3
|
1.035
|
|
PTK2
|
protein tyrosine kinase 2
|
1.035
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
1.035
|
|
H4C6
|
H4 clustered histone 6
|
1.035
|
|
DLL4
|
delta-like 4 (Drosophila)
|
1.034
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
1.033
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
1.032
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
1.031
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
1.03
|
|
HJV
|
hemojuvelin BMP co-receptor
|
1.029
|
|
DICER1
|
dicer 1, ribonuclease type III
|
1.029
|
|
CBX5
|
chromobox homolog 5
|
1.027
|
|
H4C7
|
H4 clustered histone 7
|
1.027
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
1.025
|
|
SAA1
|
serum amyloid A1
|
1.025
|
|
EDN1
|
endothelin 1
|
1.025
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
1.024
|
|
FLT4
|
fms-related tyrosine kinase 4
|
1.024
|
|
ACVR2B
|
activin A receptor, type IIB
|
1.023
|
|
PRPF40B
|
PRP40 pre-mRNA processing factor 40 homolog B (S. cerevisiae)
|
1.02
|
|
NOG
|
noggin
|
1.017
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
1.017
|
|
SMAD7
|
SMAD family member 7
|
1.016
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
1.015
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
1.012
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
1.012
|
|
IL13RA1
|
interleukin 13 receptor, alpha 1
|
1.01
|
|
TLR2
|
toll-like receptor 2
|
1.01
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
1.01
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
1.01
|
|
ERV3-1
|
endogenous retrovirus group 3, member 1
|
1.01
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
1.009
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
1.008
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
1.007
|
|
SIGLEC1
|
sialic acid binding Ig-like lectin 1, sialoadhesin
|
1.007
|
|
NANOG
|
Nanog homeobox
|
1.004
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
1.003
|
|
BRCA2
|
breast cancer 2, early onset
|
1.003
|
|
LYST
|
lysosomal trafficking regulator
|
1.002
|
|
DUSP3
|
dual specificity phosphatase 3
|
1.002
|
|
IL12RB1
|
interleukin 12 receptor, beta 1
|
1.001
|
